Refsum disease explained

Refsum disease
Synonyms:Adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease,[1] [2] [3]

Refsum disease is an autosomal recessive[4] neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. It is one of several disorders named after Norwegian neurologist Sigvald Bernhard Refsum (1907–1991).[5] [6] Refsum disease typically is adolescent onset and is diagnosed by above average levels of phytanic acid. Humans obtain the necessary phytanic acid primarily through diet. It is still unclear what function phytanic acid plays physiologically in humans, but has been found to regulate fatty acid metabolism in the liver of mice.[7]

Presentation

Individuals with Refsum disease present with neurologic damage, cerebellar degeneration, and peripheral neuropathy. Onset is most commonly in childhood or adolescence with a progressive course, although periods of stagnation or remission do occur. Symptoms include ataxia; dry, scaly skin; difficulty hearing; and eye problems, including retinitis pigmentosa, cataracts, and night blindness.[8] In 80 percent of patients diagnosed with Refsum disease, sensorineural hearing loss has been reported.[7] This is hearing loss as the result of damage to the inner ear or the nerve connectIng ear to the brain.

Cause

Refsum disease is a peroxisomal disorder caused by the impaired alpha-oxidation of branched chain fatty acids resulting in buildup of phytanic acid and its derivatives in the plasma and tissues. This may be due to deficiencies of phytanoyl-CoA hydroxylase or peroxin-7 activity, encoded by the genes PHYH[9] and PEX7,[10] respectively. In general, Refsum disease is caused by PHYH mutations.[11]

Classification

Adult Refsum disease may be divided into the adult Refsum disease 1 and adult Refsum disease 2 subtypes. The former stems from mutations in the phytanoyl-CoA hydroxylase (PAHX aka PHYH) gene, on the PHYH locus on chromosome 10p13. It was initially believed this was the sole mutation; however 55% of cases are now attributed to mutations in other genes.[13]

Refsum disease 2 stems from mutations in the peroxin 7 (PEX7) gene. The PEX7 gene is located in the region of chromosome 6q22-24, and mutations were found in patients presenting with accumulation of phytanic acid with no PHYH mutation.[14]

Adult Refsum disease should not be confused with infantile Refsum disease, a peroxisome biogenesis disorder resulting from deficiencies in the catabolism of very long chain fatty acids and branched chain fatty acids (such as phytanic acid) and plasmalogen biosynthesis.[15] Grass feeding animals and their milk are also avoided.[13] Recent research has shown that CYP4 isoform enzymes could help reduce the over-accumulation of phytanic acid in vivo.[17] Plasmapheresis is another medical intervention used to treat patients. This involves the filtering of blood to ensure there is no accumulation of phytanic acid.[13]

Biological sources of phytanic acid

In ruminant animals, the gut fermentation of consumed plant materials liberates phytol, a constituent of chlorophyll, which is then converted to phytanic acid and stored in fats.[18] Although humans cannot derive significant amounts of phytanic acid from the consumption of chlorophyll present in plant materials, it has been proposed that the great apes (chimpanzees, gorillas and orangutans) as well as other captive non-human primates can derive significant amounts of phytanic acid from the hindgut fermentation of plant materials.[19] [20]

See also

External links

Notes and References

  1. Book: Freedberg. 2003 . Fitzpatrick's Dermatology in General Medicine . 6th . McGraw-Hill . 978-0-07-138076-8 . 499. etal.
  2. Book: James, William . Berger, Timothy . Elston, Dirk . 2005 . Andrews' Diseases of the Skin: Clinical Dermatology . limited . 10th . Saunders . 978-0-7216-2921-6 . 564.
  3. Book: Rapini, Ronald P. . Bolognia, Jean L. . Jorizzo, Joseph L. . Dermatology: 2-Volume Set . Mosby . St. Louis . 2007 . 978-1-4160-2999-1 .
  4. Jayaram . H.. Downes . S. M.. Midlife diagnosis of Refsum Disease in siblings with Retinitis Pigmentosa – the footprint is the clue: a case report. Journal of Medical Case Reports. 2. 80. March 2008. 18336720. 2275283. Free full text. 10.1186/1752-1947-2-80. free.
  5. Refsum S . Heredoataxia hemeralopica polyneuritiformis - et tidligere ikke beskrevet familiært syndrom? En foreløbig meddelelse . Nordisk Medicin . 28 . 2682–6 . 1945 . no.
  6. Refsum S . Heredopathia atactica polyneuritiformis. A familial syndrome not hitherto described. A contribution to the clinical study of hereditary diseases of the nervous system . Acta Psych. Neur. . Suppl.38 . 1–303 . 1946.
  7. Nogueira, C. . Meehan, T. . O’Donoghue, G. . amp . Refsum's Disease and Cochlear Implantation . Annals of Otology, Rhinology, and Laryngology . 123 . 6 . 425–7 . 2014 . 10.1177/0003489414526846. 24690989 . 39345035 .
  8. Web site: National Institutes of Health . Synonym(s): Phytanic Acid Storage Disease, Heredopathia Atactica Polyneuritiformis . 8 July 2007 . 9 July 2007 . https://web.archive.org/web/20070709223605/http://www.ninds.nih.gov/disorders/refsum/refsum.htm . dead .
  9. Web site: PHYH gene. Medline Plus. National Library of Medicine. 3 April 2023. 1 January 2010. Bethesda, Maryland.
  10. Web site: PEX7 gene. Medline Plus. National Library of Medicine. Bethesda, Maryland. 3 April 2023. 1 July 2010.
  11. Davies. M. G.. Marks. R.. Dykes. P.J.. Reynolds. D. . 1977 . Epidermal abnormali-ties in Refsum's disease . Br J Dermatol . 97 . 4. 401–406 . 10.1111/j.1365-2133.1977.tb14248.x. 73380. 12698297.
  12. PEX7 gene mutations can interrupt the peroxisomal transport of proteins as this gene codes for the peroxin-7 protein receptor. These mutations in the PEX7 gene generally lead to rhizomelic chondrodysplasia punctata type 1, which impairs development of many parts of the body. Refsum disease is inherited in an autosomal recessive pattern, meaning that it requires both copies of the mutation to inherit the disease.

    Diagnosis

    Histopathologic examination of the skin from a suspected patient commonly shows hyperkeratosis, hyper-granulosis and acanthosis. The presence of cells in the basal and suprabasal layers of the epidermis containing variably sized vacuoles with accumulated lipids is pathognomonic for the disease.[11]

  13. Metoyer, K. . Adult Refsum Disease. In C. Noggle . The Encyclopedia of Neuropsychological Disorders .
  14. Lambert-Hamill, M. . Mitchell, J. . Wierzbicki, A. S. . Haasjes, J. . Brites, P. . Waterham, H. R. . etal . Identification of PEX7 as the Second gene involved in Refsum disease. The American Journal of Human Genetics . 72 . 2 . 471–7 . 2003. 10.1086/346093. 12522768 . 379239 .
  15. Baldwin . R. J. . 2010 . The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease . . 81 . 9 . 954–7 . 10.1136/jnnp.2008.161059 . 20547622 . 207002195 . etal.

  16. Treatment

    Since phytanic acid is not endogenously produced in the human body, individuals with Refsum disease are commonly placed on a phytanic-acid–restricted diet and avoid the consumption of fats from ruminant animals and certain fish, such as tuna, cod, and haddock.[15]

  17. Xu F, Ng VY, Kroetz DL, de Montellano PR . CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease . J. Pharmacol. Exp. Ther. . 318 . 2 . 835–9 . 2006 . 16707724 . 10.1124/jpet.106.104976 . 23068060 .
  18. 10.1023/A:1005476631419 . Verhoeven . N. M. . Wanders . R. J. . Poll-The . B. T. . Saudubray . J. M. . Jakobs . C. . The metabolism of phytanic acid and pristanic acid in man: a review . Journal of Inherited Metabolic Disease . 21 . 7 . 697–728 . 1998 . 9819701. 10325980 .
  19. Watkins . P. A. . Moser . A. B. . Toomer . C. B. . Steinberg . S. J. . Moser . H. W. . Karaman . M. W. . Ramaswamy . K. . Siegmund . K. D. . Lee . D. R. . Ely . J. J. . Ryder . O. A. . Hacia . J. G. . Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions . BMC Physiology . 10 . 19 . 2010 . 20932325 . 2964658 . 10.1186/1472-6793-10-19 . free .
  20. Moser . AB . Hey . J . Dranchak . PK . Karaman . MW . Zhao . J . Cox . LA . Ryder . OA . Hacia . JG . Diverse captive non-human primates with phytanic acid-deficient diets rich in plant products have substantial phytanic acid levels in their red blood cells. . Lipids in Health and Disease . 4 February 2013 . 12 . 10 . 10.1186/1476-511X-12-10 . 23379307. 3571895 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Refsum disease".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.